期刊文献+

丙种球蛋白治疗湿疹伴高IgE的ITP病儿效果 被引量:2

EFFECT OF GAMMA GLOBULIN ON CHILDREN WITH IMMUNE THROMBOCYTOPENIC PURPURA CONCOMITATED WITH ECZEMA AND HIGH IgE LEVEL
下载PDF
导出
摘要 目的探讨湿疹伴高血清免疫球蛋白E(IgE)的免疫性血小板减少性紫癜(ITP)病儿对丙种球蛋白的治疗反应。方法收集我科2005年2月—2010年5月收治的200例ITP病儿的临床及实验室资料。将病儿分为3组:A组(无湿疹,IgE正常)69例,B组(湿疹,高IgE)75例,C组(湿疹,IgE正常)56例。评价比较各组病儿丙种球蛋白的疗效。结果丙种球蛋白治疗后3个月,病儿总有效率为93.5%,A、B、C组总有效率分别为97.1%、90.7%、92.9%,A组疗效明显优于B、C组(χ2=32.10、7.58,P<0.017),B、C两组比较差异无显著性(P>0.05)。初诊时高IgE病儿,治疗3个月时IgE下降者62例,血小板计数均有不同程度回升,治疗总有效率为96.8%;IgE未下降者13例,治疗总有效率为61.5%,两组疗效比较差异有显著性(Z=-3.060,P<0.05)。3组血小板上升时间以B组最长,用药后血小板峰值以B组最低,出血控制时间以B组最长(F=13.319~24.707,P<0.05)。A、B、C组分别有2例(2.9%)、23例(30.7%)、6例(10.7%)转为慢性ITP,B组明显多于A、C组(χ2=19.31、7.41,P<0.017)。结论湿疹伴高IgE的ITP病儿丙种球蛋白治疗效果差,易转为慢性。 Objective To observe the curative effect of gamma globulin in the treatment of immune thrombocytopenic purpura (ITP) in children with eczema and high serum IgE level. Methods Clinical and laboratory records of 200 children with ITP treated in our hospital-- from February 2005 to May 2010-- were collected and divided into three groups as group A (69 cases, with no eczema, and normal IgE level) ; group 13 (75, with eczema and high IgE); Group C (56, with eczema and normal IgE). The response of patients in each group to gamma globulin therapy was compared. Results The total effective rate (TER) of gamma globulin was 93.5% after three months of treatment, that in groups A, B, and C was 97.1%,90.7% and 92.9%, respec- tively, that in group A being much higher than that in groups t3 and C (x2 =32.10,7.58;P〈0.05), and the difference of that be tween groups B and C, not significant (P〉0.05). The high IgE levels at first visit declined in 62 cases after three months of treat- ment, blood platelet count increased in some extent, with a TER of 96.8% ; in 13 cases with no reduction of IgE, the TER was 61. 5%, the difference of curative effect between the two groups was significant (Z= -3.060 ,P〈0.05). In group B, after medication, time consumed of platelet elevation was longest, the peak of platelet count was lowest, and the hemorrhage control time was lon- gest than groups A and C (F=13.319--24.707,P〈0.05). Two (2.9%), 23(30.7%) and six (10.7%) cases in groups A, I3 and C, respectively, progressed to chronic ITP, with group B being higher than groups A andC (X2-19.31,7.41;P 〈0.017). Con- clusion The efficacy of gamma globulin therapy for children with ITP accompanying eczema and high level IgE is poor, which may lead the disease to chronic one.
出处 《青岛大学医学院学报》 CAS 2013年第2期144-146,共3页 Acta Academiae Medicinae Qingdao Universitatis
关键词 紫癜 血小板减少性 特发性 湿疹 免疫球蛋白E 治疗结果 purpura thrombocytopenic idiopathic eczema immunoglobulin E treatment outcome
  • 相关文献

参考文献19

  • 1ZELLER B, RAJANTIE J, HEDLUND-TREUTIGER I, et al. Childhood idiopathic thrombocytopenic purpura in the Nor- dic countries: epidemiology and predictors of chronic diseases [J].Acta Paediatr, 2005,94(2):178-184.
  • 2BOLTON-MAGGS P H B. Idiopathic thrombocytopenic pur- pura[J].Arch Dis Child, 2000,83(3):220-222.
  • 3李婉丽,郑敏翠,宋国才,蒋小梅,吴攀,张本山,杨海霞.儿童特发性血小板减少性紫癜预后影响因素分析[J].中国新医药,2004,3(4):46-47. 被引量:11
  • 4吴润晖,吴敏媛,马晓莉,石慧文.儿童特发性血小板减少性紫癜患者的免疫状态研究[J].血栓与止血学,2006,12(6):245-249. 被引量:7
  • 5GLANZ J, FRANCE E, XU S, et al. A population-based, multisite cohort study ofthe predictors of chronic idiopathic thrombocytopenic purpura in children[J]. Pediatrics, 2008, 121(3) :506-512.
  • 6BRUIN M, BIERINGS M, UITERWAAL C, et al. Platelet count, previous infection and FCGR2B genotype predict devel- opment of chronic disease in newly diagnosed idiopathic thromboeytopenia in childhood: results of a prospective study[J]. Br J Hematol, 2004,127(5):561-567.
  • 7JAYABOSE A, SOMASUNDARAM M D, LEVENDOGLU T, et al. Long-term outcome of chronic idiopathic thrombocy topenic purpura in children[J]. J Pediatr Hematol Oncol, 2004,26(11) :724 -726.
  • 8WATTS R G. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the children's hospital of Alabama[J]. Clin Pediatr(Phila), 2004,43(8: 691-702.
  • 9黄花荣.小儿特发性血小板减少性紫癜临床疗效与骨髓巨核细胞数的关系[J].临床儿科杂志,2006,24(2):124-125. 被引量:10
  • 10张之南,沈悌.血液病诊断及疗效标准[M].2版.北京:科学出版社,1999:10-16.

二级参考文献30

  • 1李军民,沈志祥,王振义,黄秋爱,钱六妹,熊树民,杜心,蔡敬仁,陈淑蓉.成人慢性血小板减少性紫癜患者骨髓巨核细胞的研究[J].中华血液学杂志,1994,15(5):251-253. 被引量:35
  • 2中华医学会血液学学会血栓与止血学组.几种出血性疾病诊断(及疗效)标准的修订[J].中华血液学杂志,1995,16:331-331.
  • 3-.特发性血小板减少紫癜诊疗常规[J].中华儿科杂志,1987,25:104-105.
  • 4杨天盈 张之南 等.临床血液学进展[M].北京:北京医科大学,中国协和医科大学联合出版社,1992.313.
  • 5[2]KUHNE T,BUCHANAN GR,ZIMMERMAN S,et al.A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group[J].The Journal of Pediatrics 2003,143:605-608.
  • 6[4]NUGENT DJ.Controversies in the treatment of pediatric immune thrombocytopenias[R].Blood 2002(16):15-17.
  • 7[5]BLANCHETTE V,CARCAO M.Approach to the investigation and management of immune thrombocytopenic purpura in children[J].Seminars in Hematology.2000 ;37:299-314
  • 8[6]CINES DB,BLANCHETTE VS.Medical progress immune thrombocytopenic purpura[R].N Wngl J Med.2002,346:995-1008.
  • 9[7]COOPAMAH MD,GARVEY MB,FREEDMAN J,et al.Cellar immune mechanisms in autoimmune thrombocytopenic purpura:An update.[J].Thansfus Med Rev,2003,7(1):69-80.
  • 10[9]GARCIA-SUAREZ J,PRICETO A,REYES E,et al.Abnormal gamma IFN and alpha TNF seeretion in purified CD2 + cells from autoimmune thrombocytopenic purpura(ATP) patients:their implication in the clinical course of the disease[J].Am J Hematol,1995,49:271-276.

共引文献97

同被引文献30

  • 1王学艳,杨雪飞,张明,何欢,马瑞琴.过敏性皮肤病与食物过敏原特异性免疫球蛋白G的临床分析[J].南方医科大学学报,2006,26(1):15-15. 被引量:31
  • 2谢志贤,刘倩.食物不耐受与相关性疾病[J].中华内科杂志,2006,45(2):150-151. 被引量:257
  • 3王玲,姜辉,田亚平.普通人群14种食物不耐受情况初步分析[J].军医进修学院学报,2007,28(2):129-131. 被引量:55
  • 4孙改河.食物不耐受血清特异性IgG抗体检测在临床中的应用[J].检验医学与临床,2007,4(7):591-592. 被引量:35
  • 5MAK A, CHEUNG M W, CHIEW H J, et al. Global trend of survival and damage of systemic lupus erythematosus: meta-analy sis and recta-regression of observational studies from the 1950s to 2000s[J]. Semin Arthritis Rheum, 2012,41(6):830-839.
  • 6HOCHBERG M C. Updating the American college of rheuma- tology revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1997,40(9) : 1725.
  • 7POPESCU A, KAO A H. Neuropsychiatric systemic lupus erythematosus[-J]. Curr Neuropharmaeol, 2011,9 (3) : 449-457.
  • 8NARVAEZ J, RIOS-RODRIGUEZ V, DE LA FUENTE D, et al. Rituximab therapy in refractory neuropsychiatric lupus: current clinical evidence[-J]. Semin Arthritis Rheum, 2011,41 (3) :364-372.
  • 9TOKUNAGA M, SAITO K, KAWABATA D, et al. Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythe- matosus involving the central nervous system[J]. Ann Rheum Dis, 2007,66(4) :470-475.
  • 10MORAES-FONTES M F, LCIO I, SANTOS C, et al. Neuro- psychiatric features of a cohort of patients with systemic lupus erythematosus[J]. ISRN Rheumatol, 2012,2012:98-116.

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部